Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of March 2, 2026, Madison Square Garden Sports Corp. (MSGS) has a Wall Street consensus price target of $329.75, based on estimates from 28 covering analysts. With the stock currently trading at $331.66, this represents a potential downside of -0.6%. The company has a market capitalization of $1.50B.
Analyst price targets range from a low of $268.00 to a high of $400.00, representing a 40% spread in expectations. The median target of $325.50 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 19 analysts rating the stock as a Buy or Strong Buy,9 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, MSGS trades at a trailing P/E of -356.6x. Analysts expect EPS to grow +56.2% over the next year.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how MSGS stacks up against sector leader Netflix, Inc..
Start ComparisonWall Street's consensus price target for MSGS is $329.75, -0.6% from its current price of $331.66. The below-market target from 28 analysts suggests limited near-term appreciation.
MSGS has a consensus rating of "Buy" based on 28 Wall Street analysts. The rating breakdown is predominantly bullish, with 19 Buy/Strong Buy ratings. The consensus 12-month price target of $329.75 implies -0.6% downside from current levels.
MSGS's current price is $331.66 with a consensus target of $329.75 (-0.6% implied move). Analyst estimates suggest the stock is fairly valued at current levels.
The most bullish Wall Street analyst has a price target of $400 for MSGS, while the most conservative target is $268. The consensus of $329.75 represents the median expectation. These targets typically reflect 12-month expectations.
MSGS is heavily covered by Wall Street, with 28 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 19 have Buy ratings, 9 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month MSGS stock forecast based on 28 Wall Street analysts shows a consensus price target of $329.75, with estimates ranging from $268 (bear case) to $400 (bull case). The median consensus rating is "Buy".
Analysts are cautious on MSGS, with 0 Sell ratings and a price target of $329.75 (-0.6% from current price). The "Buy" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
MSGS analyst price targets range from $268 to $400, a 40% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $329.75 consensus represents the middle ground.